What does DR. IVICA HOLJEVAC do?

DR. IVICA HOLJEVAC is a specialist medical practice in Genk. Private Limited, started on 15 December 2014, 1 establishment.

What is the address of DR. IVICA HOLJEVAC?

The registered office of DR. IVICA HOLJEVAC is located at Armand Maclotlaan 68, 3600 Genk.

Is DR. IVICA HOLJEVAC still active?

Yes. According to the CBE (29 September 2026) DR. IVICA HOLJEVAC is active, legal situation “Normale toestand”, started on 15 December 2014.

Is DR. IVICA HOLJEVAC registered on Peppol?

Yes, DR. IVICA HOLJEVAC is registered on the Peppol network with ID 0208:0506847566.

What is the enterprise number of DR. IVICA HOLJEVAC?

The enterprise number of DR. IVICA HOLJEVAC is BE0506847566.

When was DR. IVICA HOLJEVAC founded?

DR. IVICA HOLJEVAC was founded on 15 December 2014.

Who are the directors of DR. IVICA HOLJEVAC?

According to the 2025 annual accounts, the directors of DR. IVICA HOLJEVAC are: Ivica Holjevac.

Is DR. IVICA HOLJEVAC a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 15 December 2014; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. IVICA HOLJEVAC make in 2025?

DR. IVICA HOLJEVAC posted a profit after taxes of € 43,239 in financial year 2025.

What is the revenue of DR. IVICA HOLJEVAC?

As a small company, DR. IVICA HOLJEVAC is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 96,266.

DR. IVICA HOLJEVAC (Private Limited) - Genk

Dossier DR. IVICA HOLJEVAC, printed on 29 September 2026 from databakkes.be/en/0506847566/dr-ivica-holjevac. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. IVICA HOLJEVAC from Genk, company number BE0506847566, closed financial year 2025 with a result of € 43,239 after tax. For that financial year DR. IVICA HOLJEVAC recorded a gross margin of € 96,266 and equity of € 76,198. Compared with financial year 2024, the result moved from € 43,920 to € 43,239. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 16, 2026.

What it is worth Healthy

€ 76,198

▼ 8% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 43,239

▼ 2% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 80,568

▼ 13% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 50,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 52,881

▼ 29% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 42,145

▼ 33% vs 2024

€ 16,319 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 2,345

▲ € 2,310 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 94,762 Gross margin 2022: € 94,762 First fiscal year in the series	€ 109,965 Gross margin 2023: € 109,965 ▲ 16% vs 2022 (€ 94,762) Favourable step	€ 96,593 Gross margin 2024: € 96,593 ▼ 12% vs 2023 (€ 109,965) Unfavourable step	€ 96,266 Gross margin 2025: € 96,266 Unchanged (€ 96,593) Unfavourable step
Profit after taxes	€ 48,400 Profit after taxes 2022: € 48,400 First fiscal year in the series	€ 61,940 Profit after taxes 2023: € 61,940 ▲ 28% vs 2022 (€ 48,400) Favourable step	€ 43,920 Profit after taxes 2024: € 43,920 ▼ 29% vs 2023 (€ 61,940) Unfavourable step	€ 43,239 Profit after taxes 2025: € 43,239 ▼ 2% vs 2024 (€ 43,920) Unfavourable step	▼ 2%
Equity	€ 127,098 Equity 2022: € 127,098 First fiscal year in the series	€ 119,038 Equity 2023: € 119,038 ▼ 6% vs 2022 (€ 127,098) Unfavourable step	€ 82,958 Equity 2024: € 82,958 ▼ 30% vs 2023 (€ 119,038) Unfavourable step	€ 76,198 Equity 2025: € 76,198 ▼ 8% vs 2024 (€ 82,958) Unfavourable step	▼ 8%
Total debts	€ 64,816 Total debts 2022: € 64,816 First fiscal year in the series	€ 131,774 Total debts 2023: € 131,774 ▲ 103% vs 2022 (€ 64,816) Unfavourable step	€ 144,558 Total debts 2024: € 144,558 ▲ 10% vs 2023 (€ 131,774) Unfavourable step	€ 95,911 Total debts 2025: € 95,911 ▼ 34% vs 2024 (€ 144,558) Favourable step	▼ 34%
Cash	€ 90,492 Cash 2022: € 90,492 First fiscal year in the series	€ 54,634 Cash 2023: € 54,634 ▼ 40% vs 2022 (€ 90,492) Unfavourable step	€ 92,370 Cash 2024: € 92,370 ▲ 69% vs 2023 (€ 54,634) Favourable step	€ 80,568 Cash 2025: € 80,568 ▼ 13% vs 2024 (€ 92,370) Unfavourable step	▼ 13%
Retained profit	€ 107,098 Retained profit 2022: € 107,098 First fiscal year in the series	€ 105,672 Retained profit 2023: € 105,672 ▼ 1% vs 2022 (€ 107,098) Unfavourable step	€ 69,592 Retained profit 2024: € 69,592 ▼ 34% vs 2023 (€ 105,672) Unfavourable step	€ 62,831 Retained profit 2025: € 62,831 ▼ 10% vs 2024 (€ 69,592) Unfavourable step	▼ 10%
Dividend	€ 35,294 Dividend 2022: € 35,294 First fiscal year in the series	€ 63,366 Dividend 2023: € 63,366 ▲ 80% vs 2022 (€ 35,294) Unchanged	€ 80,000 Dividend 2024: € 80,000 ▲ 26% vs 2023 (€ 63,366) Unchanged	€ 50,000 Dividend 2025: € 50,000 ▼ 37% vs 2024 (€ 80,000) Unchanged	▼ 37%
Bank debt	€ 23,171 Bank debt 2022: € 23,171 First fiscal year in the series	€ 79,510 Bank debt 2023: € 79,510 ▲ 243% vs 2022 (€ 23,171) Unfavourable step	€ 62,852 Bank debt 2024: € 62,852 ▼ 21% vs 2023 (€ 79,510) Favourable step	€ 42,145 Bank debt 2025: € 42,145 ▼ 33% vs 2024 (€ 62,852) Favourable step	▼ 33%
Balance sheet total	€ 191,914 Balance sheet total 2022: € 191,914 First fiscal year in the series	€ 250,812 Balance sheet total 2023: € 250,812 ▲ 31% vs 2022 (€ 191,914) Unchanged	€ 227,516 Balance sheet total 2024: € 227,516 ▼ 9% vs 2023 (€ 250,812) Unchanged	€ 172,109 Balance sheet total 2025: € 172,109 ▼ 24% vs 2024 (€ 227,516) Unchanged	▼ 24%

Key figures of DR. IVICA HOLJEVAC, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. IVICA HOLJEVAC?

What happened at DR. IVICA HOLJEVAC in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 16, 2026 New annual accounts for financial year 2025: profit of € 43,239 (▼ 2% vs 2024). Source: NBB ↗
Dec 15, 2014 New establishment in Genk. KBO
Dec 15, 2014 Start of the company according to the CBE. KBO

In short

From € 48,400 profit in 2022 to € 43,239 profit in 2025.

Paid € 55,159 in corporate taxes since 2022.

Best year ever: 2023, with € 61,940 profit.

Paid out € 228,660 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. IVICA HOLJEVAC? We notify you, reason included.

Follow DR. IVICA HOLJEVAC

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Ivica Holjevac

DR. IVICA HOLJEVAC

Behind DR. IVICA HOLJEVAC is Ivica Holjevac.

See the full network in the app

Directors

According to the 2025 annual accounts

Ivica Holjevac

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Armand Maclotlaan 68

3600 Genk

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Atelier Daniels VOF

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0506.847.566
VAT number: BE 0506.847.566
Registered office: Armand Maclotlaan 68, 3600 Genk
Names & denominations: DR. IVICA HOLJEVAC
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 15 December 2014
Peppol: Active · Active since 11 Dec 2024
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗